Trademark search for:

STRAFIDA

EXPIRED USPTO USPTO

USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2015-04-07 — Application filed
2015-05-14 — Sn assigned for sect 66a appl from ib
2015-05-15 — Application filed
2015-05-19 — Application filed
2015-07-15 — Assigned to examiner
2015-07-16 — Approved for pub - principal register
2015-08-05 — Notice of publication
2015-08-05 — Notice of start of opposition period created, to be sent to ib
2015-08-05 — Notification of possible opposition sent to ib
2015-08-21 — Notification processed by ib
2015-08-25 — Published for opposition
2015-11-10 — Registered-principal register
2015-12-10 — Grant of protection created, to be sent to ib
2016-01-20 — Final disposition recorded
2016-01-20 — Final disposition recorded
2016-02-05 — Notification processed by ib
2021-08-06 — Change of name/address rec'd from ib
2021-11-21 — New representative at ib received
2021-12-04 — New representative at ib received
2022-05-27 — Cancelled section 71
2023-01-27 — Total invalidation of reg ext protection created
2023-03-20 — Invalidation processed
2023-03-20 — Total invalidation of reg ext protection sent to ib
2023-04-12 — Total invalidation processed by the ib
2025-04-07 — Final status recorded
2025-10-31 — Death of international registration

Owner Information

Novo Nordisk Health Care AG
CH

Novo Nordisk Health Care AG
CH

Novo Nordisk Health Care AG
CH

Correspondent

Isler & Pedrazzini AG
Postfach 1772
CH-8027 Zürich,
SWITZERLAND

Filing Details

Filing Date:
2015-04-07

Status Date:
2025-04-07

Category:
Pharmaceuticals

Filing Year:
2015

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.